A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

This study is comparing two versions of a conditioning regimen — carmustine alone versus carmustine with ethanol — used before a stem cell transplant in people with Hodgkin or non-Hodgkin lymphoma. The goal is to see if the combination is safer and more effective. **You may be eligible if...** - You are 18 or older with a life expectancy of at least 6 months - You have been diagnosed with Hodgkin or non-Hodgkin lymphoma and have responded (fully or partially) to treatment - You are being considered for an autologous (your own cells) stem cell transplant - You have collected enough stem cells through apheresis - Your heart and lung function meet minimum thresholds - You test negative for HIV, hepatitis C, active hepatitis B, and syphilis **You may NOT be eligible if...** - You have previously had a stem cell transplant (autologous or donor) - You have had significant radiation to critical organs - You have another active cancer or myelodysplasia - You have active lymphoma still present in your bone marrow Talk to your doctor to see if this trial is right for you.